You are here: Industry Insights > EU

News List

EU regulators review Novartis’ migraine drug pharmatimes
June 23, 2017
An experimental therapy being developed by Amgen and Novartis to prevent migraine has been accepted for review in the European Union.
TraceLink expands European HQ to accommodate 207% EU employee growth in 2017 newsnow
June 15, 2017
TraceLink has announced that it will relocate its European headquarters to a larger, newly renovated office space in Uxbridge, UK.
TraceLink Introduces New EU FMD Compliance Technology contractpharma
June 08, 2017
Unveils industry’s first Compliance and Digital Information Platform for pharmacies with EU FMD requirements
Spinraza approved in the EU as first treatment for spinal muscular atrophy cphi-online
June 06, 2017
Robust data from Phase III studies demonstrated positive impact on motor milestone achievement; increased survival in infants with SMA.
EU approves Opdivo for bladder cancer pharmatimes
June 06, 2017
Bristol-Myers Squibb’s Opdivo has picked up approval for its eighth indication in Europe, having won clearance for the treatment of a subset of patients with metastatic urothelial carcinoma (mUC).
Pfizer’s Trumenba to challenge GlaxoSmithKline's Bexsero with EU nod fiercepharma
June 01, 2017
Meningococcal group B vaccine Bexsero has been helping drive revenue growth for GlaxoSmithKline, but now, with a European approval, Pfizer’s Trumenba is set to challenge it in that lucrative market.
First approval for Keytruda in a hematologic malignancy in the EU cphi-online
May 08, 2017
European Commission approves Keytruda for patients with relapsed or refractory classical Hodgkin lymphoma who failed ASCT and BV or who are transplant-ineligible and have failed BV.
Janssen scores EU approval for blood cancer drug Darzalex pharmafile
May 03, 2017
Janssen has announced that its CD38-directed monoclonal antibody Darzalex (daratumumab) has expanded its indication ...
EU expands use of Janssen’s Darzalex pharmatimes
May 03, 2017
EU regulators have expanded the scope of Janssen’s Darzalex to include patients with multiple myeloma who have...
EU issues full approval for AZ’ Tagrisso pharmatimes
April 27, 2017
European regulators have now issued a full approval for AstraZeneca’s lung cancer drug Tagrisso, having awarded the drug a conditional approval in February last year.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 21 22 Next page